These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 2182946

  • 21. Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.
    Talmadge JE, Tribble HR, Pennington RW, Phillips H, Wiltrout RH.
    Cancer Res; 1987 May 15; 47(10):2563-70. PubMed ID: 3105865
    [Abstract] [Full Text] [Related]

  • 22. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S, Vigon I, Dusanter I, Charon M, Velu T, Baillou C, Gisselbrecht S, Lemoine FM.
    J Immunol; 1995 Feb 15; 154(4):1577-86. PubMed ID: 7836743
    [Abstract] [Full Text] [Related]

  • 23. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ, Ince C, Rosenblum MG, Gallick GE.
    J Cell Biochem; 1989 Nov 15; 41(3):139-57. PubMed ID: 2482293
    [Abstract] [Full Text] [Related]

  • 24. Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha.
    Nishihara K, Barth RF, Wilkie N, Lang JC, Oda Y, Kikuchi H, Everson MP, Lotze MT.
    Cancer Gene Ther; 1995 Jun 15; 2(2):113-24. PubMed ID: 7621259
    [Abstract] [Full Text] [Related]

  • 25. NIH3T3 fibroblasts transformed by the dbl oncogene show altered expression of bradykinin receptors: effect on inositol lipid turnover.
    Ruggiero M, Srivastava SK, Fleming TP, Ron D, Eva A.
    Oncogene; 1989 Jun 15; 4(6):767-71. PubMed ID: 2543945
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.
    Buchdunger E, Zimmermann J, Mett H, Meyer T, Müller M, Druker BJ, Lydon NB.
    Cancer Res; 1996 Jan 01; 56(1):100-4. PubMed ID: 8548747
    [Abstract] [Full Text] [Related]

  • 27. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: the role of tumor necrosis factor-alpha.
    Murakami A, Kawabata K, Koshiba T, Gao G, Nakamura Y, Koshimizu K, Ohigashi H.
    Cancer Res; 2000 Nov 15; 60(22):6326-31. PubMed ID: 11103793
    [Abstract] [Full Text] [Related]

  • 28. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
    Heidenreich S, Weyers M, Gong JH, Sprenger H, Nain M, Gemsa D.
    J Immunol; 1988 Mar 01; 140(5):1511-8. PubMed ID: 3126228
    [Abstract] [Full Text] [Related]

  • 29. Augmentation by IL-1 alpha of tumor necrosis factor-alpha cytotoxicity in cells transfected with adenovirus E1A.
    Tsuji Y, Ninomiya-Tsuji J, Torti SV, Torti FM.
    J Immunol; 1993 Mar 01; 150(5):1897-907. PubMed ID: 8436824
    [Abstract] [Full Text] [Related]

  • 30. Neutral red uptake and clonogenic survival assays of the hyperthermic sensitization of tumor cells to tumor necrosis factor.
    Tomasovic SP, Barta M, Klostergaard J.
    Radiat Res; 1989 Aug 01; 119(2):325-37. PubMed ID: 2756121
    [Abstract] [Full Text] [Related]

  • 31. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
    Gapuzan ME, Schmah O, Pollock AD, Hoffmann A, Gilmore TD.
    Oncogene; 2005 Sep 29; 24(43):6574-83. PubMed ID: 16027734
    [Abstract] [Full Text] [Related]

  • 32. Effect of TNF-alpha on LH and IGF-I modulated chicken granulosa cell proliferation and progesterone production during follicular development.
    Onagbesan OM, Mast J, Goddeeris B, Decuypere E.
    J Reprod Fertil; 2000 Nov 29; 120(2):433-42. PubMed ID: 11058460
    [Abstract] [Full Text] [Related]

  • 33. Comparative in vitro studies of the potentiation of tumor necrosis factor (TNF)-alpha, TNF-beta, and TNF-SAM2 cytotoxicity by hyperthermia.
    Tomasovic SP, Lu S, Klostergaard J.
    J Immunother (1991); 1992 Feb 29; 11(2):85-92. PubMed ID: 1571335
    [Abstract] [Full Text] [Related]

  • 34. An immortalized cell line expresses properties of activated microglial cells.
    Bocchini V, Mazzolla R, Barluzzi R, Blasi E, Sick P, Kettenmann H.
    J Neurosci Res; 1992 Apr 29; 31(4):616-21. PubMed ID: 1578513
    [Abstract] [Full Text] [Related]

  • 35. Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF.
    Chen MJ, Holskin B, Strickler J, Gorniak J, Clark MA, Johnson PJ, Mitcho M, Shalloway D.
    Nature; 1992 Apr 29; 330(6148):581-3. PubMed ID: 2960901
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors.
    Rasmussen CA, Pace JL, Banerjee S, Phillips TA, Hunt JS.
    Placenta; 1999 Apr 29; 20(2-3):213-22. PubMed ID: 10195744
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.